CANCOMBINO 16MG/12,5 MG TBL NOB 28 I

What is the maximum co-payment for CANCOMBINO?

If the insurance company contributes, the maximum co-payment is 90,56 Kč. The maximum pharmacy price is 172,28 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does CANCOMBINO have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

81,72 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe CANCOMBINO?

Prescription is not conditional on a medical specialization.

What is the composition of CANCOMBINO?

Kandesartan-cilexetil (16 mg), hydrochlorothiazid (12,5 mg), monohydrát laktosy, kukuřičný škrob, neznámá látka s kódem 4336, neznámá látka s kódem 4688, neznámá látka s kódem 4461, červený oxid železitý, magnesium-stearát. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to CANCOMBINO?

The medicine belongs to ATC group C09DA06 – KANDESARTAN A DIURETIKA. Medicines with the same active substance can be found here.

Who manufactures CANCOMBINO?

Krka, d.d., Novo mesto, Novo mesto (SLO)

Is the medicine in shortage?

The latest report from the manufacturer is from 27. 2. 2024. Production was terminated with effect from 27. 2. 2024. The manufacturer lists medicines with the following code as a potential substitute: